Personalized cell therapy involves the use of patient-specific cells to treat various diseases and conditions. This approach offers targeted and customized treatment options, resulting in better patient outcomes. The market for personalized cell therapy is driven by the rising prevalence of chronic diseases, such as cancer and autoimmune disorders, which require advanced treatment options.  Personalized Cell Therapy Market to reach US$ 53.8 Bn by 2027. Market Analysis By Cell Type, Therapeutic Area, and Region.